|
|
Article: CollaGenex Pharmaceuticals Reports Financial Results for the Fourth Quarter and Year 2004; Fourth Quarter Net Income Allocable to Common Stockholders of $0.21 per Share.
- Article from:
- Business Wire
- Article date:
- March 10, 2005
CopyrightCOPYRIGHT 2005 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
NEWTOWN, Pa. -- CollaGenex Pharmaceuticals, Inc. (NASDAQ:CGPI) today reported financial results for the fourth quarter and twelve months ended December 31, 2004.
Net product sales decreased 1% to $13.0 million in the fourth quarter of 2004 compared to $13.1 million in the fourth quarter of 2003. Total revenues were $13.2 million, a decrease of 6% from $14.1 million in total revenues in the fourth quarter of 2003. CollaGenex earned gross margins of 85.8% of net product sales in the fourth quarter of 2004 compared with gross margins of 86.3% of net product sales in the fourth quarter of 2003.
During the fourth quarter of 2004, net income increased 45% to ...